Hasta la próxima

Auto reproducción

Acute Lymphoblastic Leukemia: Challenges in MRD Testing

2 vistas • 08/04/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción